Immunome Inc. Contracts & Agreements

78 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Lease dated October 5, 2023, by and between the Company and Nitrogen Propco 2020, L.P., as amended by the First Amendment to Lease dated May 13, 2024, and as amended by the Second...
Lease Agreements
Immunome Inc.
Biotechnology
2025
Amendment #1 to Master License Agreement, by and between Morphimmune, Inc. and Purdue Research Foundation, dated October 16, 2024
License Agreements
Immunome Inc.
Biotechnology
2025
Immunome, Inc. 2024 Inducement Plan and Forms of Executive and Non-Executive Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder
Stock Agreements
Immunome Inc.
Biotechnology
2025
Forms of Executive and Non-Executive Stock Option Grant Notice, Option Agreement and Notice of Exercise for the 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
2025
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC, Leerink Partners LLC, and Guggenheim Securities, LLC, dated January 29, 2025
Underwriting Agreements
Immunome Inc.
Biotechnology
2025
Relocation Offer Letter dated January 20, 2025, by and between the Company and Max Rosett
Immunome Inc.
Biotechnology
2025
Amendment No. 2 to License Agreement between Immunome, Inc. and Bristol-Myers Squibb Company
License Agreements
Immunome Inc.
Biotechnology
DE
2024
Asset Purchase Agreement dated October 25, 2024, by and among the Company, Zentalis Pharmaceuticals, Inc. and Zeno Management, Inc
Purchase Agreements
Immunome Inc.
Biotechnology
WA
2024
Stock Issuance Agreement dated October 25, 2024, by and between the Company and Zentalis Pharmaceuticals, Inc
Stock Agreements
Immunome Inc.
Biotechnology
DE
2024
Employment Offer Letter dated June 17, 2024, by and between Immunome, Inc. and Phil Tsai
Employment Agreements
Immunome Inc.
Biotechnology
2024
Sales Agreement, by and between Immunome, Inc. and TD Securities (USA) LLC, dated May 14, 2024
Sales Agreements
Immunome Inc.
Biotechnology
NY
2024
Employment Offer dated November 30, 2023, by and between the Registrant and Philip Roberts
Employment Agreements
Immunome Inc.
Biotechnology
CA
2024
Amendment No. 1 to Executive Employment Agreement dated December 1, 2023, by and between the Registrant and Clay B. Siegall, Ph.D
Employment Agreements
Immunome Inc.
Biotechnology
WA
2024
Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Sandra G. Stoneman
Employment Agreements
Immunome Inc.
Biotechnology
2024
Amended and Restated Employment Offer Terms dated December 21, 2023, by and between the Registrant and Bruce Turner, M.D., Ph.D
Employment Agreements
Immunome Inc.
Biotechnology
2024
Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Max Rosett
Employment Agreements
Immunome Inc.
Biotechnology
2024
Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Jack Higgins, Ph.D
Employment Agreements
Immunome Inc.
Biotechnology
2024
Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Robert Lechleider, M.D
Employment Agreements
Immunome Inc.
Biotechnology
2024
Employment Offer Letter dated February 7, 2024, by and between the Registrant and Kinney Horn
Employment Agreements
Immunome Inc.
Biotechnology
CA
2024
License Agreement, by and between the registrant and Zentalis Pharmaceuticals, Inc., dated January 5, 2024
License Agreements
Immunome Inc.
Biotechnology
PA
2024
Separation Agreement effective October 2, 2023, by and between the Registrant and Dennis Giesing
Separation Agreements
Immunome Inc.
Biotechnology
2024
Consulting Agreement dated October 2, 2023, by and between the Registrant and Dennis Giesing
Consulting Agreements
Immunome Inc.
Biotechnology
PA
2024
Separation Agreement effective October 3, 2023, by and between the Registrant and Purnanand D. Sarma, Ph.D
Separation Agreements
Immunome Inc.
Biotechnology
2024
Asset Purchase Agreement dated December 22, 2023, by and between the Registrant and Atreca, Inc
Purchase Agreements
Immunome Inc.
Biotechnology
DE
2024
Employment Offer dated April 26, 2021, by and between the Registrant and Bob Lapetina
Employment Agreements
Immunome Inc.
Biotechnology
PA
2024
License Agreement dated November 29, 2017, by and between Immunome, Inc. (as assignee) and Bristol-Myers Squibb Company, as amended
License Agreements
Immunome Inc.
Biotechnology
DE
2024
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC, Leerink Partners LLC, and Guggenheim Securities, LLC, dated February 13, 2024
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2024
Form of Ayala Pharmaceuticals, Inc. Support Agreement, dated February 5, 2024
Immunome Inc.
Biotechnology
DE
2024
Asset Purchase Agreement dated February 5, 2024, by and between the Company and Ayala Pharmaceuticals, Inc
Purchase Agreements
Immunome Inc.
Biotechnology
NJ
2024
Consulting Agreement by and between the Company and Corleen Roche, effective as of January 2, 2024, as supplemented by Task Order #1
Consulting Agreements
Immunome Inc.
Biotechnology
PA
2023
Separation Agreement by and between the Company and Corleen Roche, dated December 22, 2023
Separation Agreements
Immunome Inc.
Biotechnology
PA
2023
Third Amended and Restated Non-Employee Director Compensation Policy, effective October 27, 2023
Compensation Agreements
Immunome Inc.
Biotechnology
2023
2020 Immunome, Inc. Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
DE
2023
Master Sponsored Research Agreement, by and among Morphimmune, Inc., Purdue Research Foundation, and Purdue University, dated February 1, 2022, as amended by that certain...
Immunome Inc.
Biotechnology
IN
2023
Master License Agreement, by and between Morphimmune, Inc. and Purdue Research Foundation, dated as of January 19, 2021, as modified pursuant to that certain email by Max Rosett...
License Agreements
Immunome Inc.
Biotechnology
IN
2023
Morphimmune, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
DE
2023
Forms of Restricted Stock Purchase Agreement, Stock Option Agreement and Early Exercise Stock Purchase Agreement under the Morphimmune, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
DE
2023
Form of Morphimmune, Inc. Indemnification Agreement
Indemnification Agreements
Immunome Inc.
Biotechnology
DE
2023
Employment Agreement, dated June 28, 2023, by and between Immunome, Inc. and Clay B. Siegall, Ph.D
Employment Agreements
Immunome Inc.
Biotechnology
WA
2023
Form of Subscription Agreement, dated June 29, 2023
Subscription Agreements
Immunome Inc.
Biotechnology
2023
Form of Lock-Up Agreement, dated June 29, 2023
Immunome Inc.
Biotechnology
2023
Form of Morphimmune, Inc. Stockholder Support Agreement, dated June 29, 2023
Immunome Inc.
Biotechnology
DE
2023
Form of Immunome, Inc. Stockholder Support Agreement, dated June 29, 2023
Immunome Inc.
Biotechnology
DE
2023
Agreement and Plan of Merger and Reorganization, dated June 29, 2023, by and among Immunome, Inc., Ibiza Merger Sub, Inc. and Morphimmune, Inc
Merger Agreements
Immunome Inc.
Biotechnology
DE
2023
Letter Agreement by and between the registrant and the Whitehead Institute for Biomedical Research, dated November 17, 2022
Immunome Inc.
Biotechnology
2023
Description of Securities
Immunome Inc.
Biotechnology
2023
Amendment #2 to the License Agreement by and between the registrant and Arrayjet Limited, dated December 30, 2022
License Agreements
Immunome Inc.
Biotechnology
2023
Employment Agreement between the Company and Dennis Giesing effective April 7, 2021
Employment Agreements
Immunome Inc.
Biotechnology
PA
2023
Amended and Restated Employment Agreement of Matthew Robinson effective June 16, 2022
Employment Agreements
Immunome Inc.
Biotechnology
PA
2023
Modification of Contract between the Company and the Department of Defense, United States of America, dated January 4, 2023
Modification Agreements
Immunome Inc.
Biotechnology
2023
Letter to Holders of Series B Warrants to Purchase Shares of Common Stock
Stock Agreements
Immunome Inc.
Biotechnology
2022
Second Amended and Restated Non-Employee Director Compensation Policy, effective as of June 15, 2022
Compensation Agreements
Immunome Inc.
Biotechnology
2022
Modification of Contract between the Company and the Department of Defense, United States of America, dated March 18, 2022 (portions of this exhibit (indicated by asterisks) have...
Modification Agreements
Immunome Inc.
Biotechnology
2022
Immunome, Inc. Annual Employee Bonus Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
2022
Description of Securities
Immunome Inc.
Biotechnology
2022
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Immunome Inc.
Biotechnology
2021
Fourth Amendment to Second Amended and Restated Management Services Agreement, dated June 1, 2021, by and between the Company and Broadband Capital Partners LLC
Management Agreements
Immunome Inc.
Biotechnology
NY
2021
Second Amended and Restated Employment Agreement, dated August 1, 2021, by and between the Company and Dr. Morin
Employment Agreements
Immunome Inc.
Biotechnology
PA
2021
Modification of Contract between the Company and the Department of Defense, United States of America, dated May 19, 2021 (portions of this exhibit (indicated by asterisks) have...
Modification Agreements
Immunome Inc.
Biotechnology
2021
Engagement Letter, dated April 9, 2021, as amended on April 25, 2021, by and among Immunome, Inc. and Ladenburg Thalmann & Co. Inc
Immunome Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated April 26, 2021, by and among Immunome, Inc. and the Purchasers signatory thereto
Purchase Agreements
Immunome Inc.
Biotechnology
NY
2021
Form of Warrant
Warrant Agreements
Immunome Inc.
Biotechnology
NY
2021
Employment Letter Agreement between the Company and Corleen M. Roche
Employment Agreements
Immunome Inc.
Biotechnology
PA
2021
Master Services Agreement, between the Company and Abzena (San Diego) Inc dated December 14, 2020
Services Agreements
Immunome Inc.
Biotechnology
DE
2021
Employment Agreement between the Company and Sandra G. Stoneman effective October 19, 2020
Employment Agreements
Immunome Inc.
Biotechnology
PA
2021
Description of Securities
Immunome Inc.
Biotechnology
2021
Separation Agreement and General Release between the Company and Richard Fitzgerald, dated December 1, 2020
Separation Agreements
Immunome Inc.
Biotechnology
PA
2020
Second Amendment to License Agreement by and between the registrant and Thomas Jefferson University, dated July 28, 2020
License Agreements
Immunome Inc.
Biotechnology
2020
Amended and Restated Employment Agreement by and between the registrant and Michael J. Morin, dated September 23, 2020
Employment Agreements
Immunome Inc.
Biotechnology
PA
2020
Amended and Restated Employment Agreement by and between the registrant and Purnanand D. Sarma, dated September 23, 2020
Employment Agreements
Immunome Inc.
Biotechnology
MA
2020
Non-Employee Director Compensation Policy
Compensation Agreements
Immunome Inc.
Biotechnology
2020
Offer Letter Agreement by and between the registrant and Richard F. Fitzgerald, dated September 18, 2020
Immunome Inc.
Biotechnology
PA
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Immunome Inc.
Biotechnology
2020
Forms of Stock Option Grant Notice, Option Agreement, RSU Award Grant Notice and Notice of Exercise for the 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
2020
2020 Equity Incentive Plan
Bonus & Incentive Agreements
Immunome Inc.
Biotechnology
DE
2020
Form of Amendment to 2020 Series A Preferred Stock Warrants
Stock Agreements
Immunome Inc.
Biotechnology
DE
2020
Form of Common Stock Certificate
Stock Agreements
Immunome Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2020